The iai test systems, or iai tests, are innovative laboratory diagnostics solutions for periodontology developed by ParoX GmbH from Leipzig and marketed jointly with IAI AG from Switzerland.
The iai test systems began with the Institute for Applied Immunology IAI AG, which was founded in Horgen in 1986. Initially, the focus of its activities was on serum production. When biologist Dr. Herrmann Wolf took over the management of the company in 1993, the focus of activities shifted towards molecular biology and specialization in dental medicine. Products such as genotyping and various biodiversity studies formed the basis for the successful development of IAI AG. Building on this, the first microbiological detection method for periodontitis diagnostics, the iai PadoTest 4-5, was developed and launched on the market to great acclaim.
Based on the expertise of its Managing Director Prof. Dr. Jörg Gabert, ParoX GmbH in Germany developed its own detection system for periodontitis bacteria in 2014 and marketed it under the name ParoProof® from Leipzig. The potential of laboratory diagnostics in periodontology was quickly recognized and partners were sought in order to expand further. This led to a cooperation with IAI AG in 2017, whereby the latter, as the oldest provider in the German-speaking region, was given priority over the established iai PadoTest®. From then on, ParoX concentrated its resources on the development of innovative diagnostic procedures.
ParoX's development work and IAI's sales opportunities ultimately led to the introduction of the first patient-available microbiome analysis in periodontology. After several years of development work, PadoBiom® was successfully launched on the market.
In 2024, the now established partners decided to enter the market together and reorganize the sales structure. As the manufacturer of the PadoBiom® and PadoTest® sampling kits, the innovative ParoX GmbH laboratory will also take over sales in the EU and worldwide. IAI AG remains responsible in Switzerland and continues to expand its activities there.
Under the leadership of ParoX GmbH, both partners are continuously working on the development of new diagnostic procedures and are cooperating with universities in Switzerland, Germany and England, as well as numerous scientific research institutions. Participation in studies serves to improve and further develop existing products.